FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
The Standard on MSN6 小时
The liberation of Auschwitz, 80 years ago
The Allied soldiers who liberated Auschwitz on January 27, 1945 discovered an unprecedented factory of death. Regarding what he expected when entering the gates of Auschwitz, Ivan Martynushkin, a ...
Biogen Inc.: FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment ...
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...